Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

BISACODYL DELAYED RELEASE TABLETS

Awarded
SPE2DP26F7379Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency has awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, with a CAGE code of 1UNB0, for the supply of BISACODYL DELAYED RELEASE TABLETS identified by NSN 6505016030287 and PR 7017476155. The total contract value is $2.46, and the award was issued on July 13, 2026. This action is part of a federal procurement effort through the DIBBS platform, reflecting a direct acquisition by the Department of Defense for a single pharmaceutical product. The contract does not specify a set-aside type, NAICS code, or detailed performance location, and the point of contact information is not provided. The delivery order is administered under the broader procurement vehicle SPE2DX25D9900, with the official record accessible via the DIBBS website using the provided link.

General Info

DMS PHARMACEUTICAL GROUP to supply bisacodyl tablets for $2.46 under DLA contract dated July 13, 2026.

Contract Value

$2.46

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP-26-F-7379 - Bisacodyl Delayed Release Tablets

PDF, High priority: read this firstaward
High

SPE2DP26F7379.pdf

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7379 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $2.46 Award Date: 07-13-2026 Delivery order under: SPE2DX25D9900 Line items: - BISACODYL DELAYED RELEASE TABLETS (NSN/Part 6505016030287, PR 7017476155)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS